News

Deal Announcements

Apellis Pharma Nets $6 Million Venture Capital Equity

Wednesday, August 7, 2013 5:33:00 AM PDT | VentureDeal
   Crestwood, Kentucky  --  Apellis Pharmaceuticals has garnered $6 million in venture capital equity investment, according to an SEC regulatory filing.

Apellis is developing peptide drugs focused on the immunology space and in the area of severe asthma and chronic obstructive pulmonary disease..

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Apellis is still seeking $2 million in additional equity financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1